Gastroenterologie Oesophagus Neoplasie

En | De
Sie sind hier: Gastroenterologie » Oesophagus » Neoplasie 26. März 2023
Erweiterte Suche
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 1601  vorhergehende Seite nächste Seite
   Artikel 1 - 20 / 32019  
Neoadjuvant radiochemotherapy and perioperative chemotherapy does not represent a standard at same priority level for oesophageal adenocarcinomas (in regard to "Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up").
Ann Oncol
Cellini F, Manfrida S, Gambacorta MA, Valentini V.
PMID: 36965575 [PubMed - as supplied by publisher]

Impact of the COVID-19 pandemic on reported cancer diagnoses in Bavaria, Germany.
J Cancer Res Clin Oncol
Voigtländer S, Hakimhashemi A, Grundmann N, Radespiel-Tröger M, Inwald EC, Ortmann O, Gerken M, Klug SJ, Klinkhammer-Schalke M, Meyer M, Müller-Nordhorn J.
PMID: 36964405 [PubMed - as supplied by publisher]

Prognostic impact of endoscopic response evaluation after neoadjuvant chemotherapy for esophageal squamous cell carcinoma: a nationwide validation study.
Matsuda S, Kitagawa Y, Okui J, Okamura A, Kawakubo H, Takemura R, Kono K, Muto M, Kakeji Y, Takeuchi H, Watanabe M, Doki Y.
PMID: 36964333 [PubMed - as supplied by publisher]

Tobacco and other risk factors for esophageal squamous cell carcinoma in Lilongwe Malawi: Results from the Lilongwe esophageal cancer case: Control study.
PLOS Glob Public Health
Kaimila B, Mulima G, Kajombo C, Salima A, Nietschke P, Pritchett N, Chen Y, Murphy G, Dawsey SM, Gopal S, Phiri KS, Abnet CC.
PMID: 36962303 [PubMed - as supplied by publisher]

Multidisciplinary nutritional management improves nutritional and hospitalized outcomes of patients with esophageal cancer undergoing chemoradiotherapy: A randomized control trial.
Medicine (Baltimore)
Wang SA, Li F, Zhu J, Chen X, Ren W, Gao B.
PMID: 36961192 [PubMed - as supplied by publisher]

The association between statin use and prognosis in esophageal cancer patients: A meta-analysis.
Medicine (Baltimore)
Lv J, Chen P, Wu J, Wen Z, Zhao C.
PMID: 36961185 [PubMed - as supplied by publisher]

A retrospective study of adjuvant proton radiotherapy for breast cancer after lumpectomy: a comparison of conventional-dose and hypofractionated dose.
Radiat Oncol
Hong Z, Yang Z, Mei X, Li P, Bao C, Wang Z, Cai X, Ming X, Wang W, Guo X, Yu X, Zhang Q.
PMID: 36959653 [PubMed - in process]

Noncoding RNAs as regulators of STAT3 pathway in gastrointestinal cancers: Roles in cancer progression and therapeutic response.
Med Res Rev
Ashrafizadeh M, Mohan CD, Rangappa S, Zarrabi A, Hushmandi K, Kumar AP, Sethi G, Rangappa KS.
PMID: 36951271 [PubMed - as supplied by publisher]

Oncological and physiological impact of thoracic duct resection in esophageal cancer.
Dis Esophagus
Matsuda S, Takeuchi M, Kawakubo H, Takeuchi H, Kitagawa Y.
PMID: 36950928 [PubMed - as supplied by publisher]

Radiotherapy and olaparib in combination for carcinoma of the oesophagus: A phase I study.
Clin Transl Radiat Oncol
Sheikh H, Ryder D, Bateman A, Chalmers A, Jackson A.
PMID: 36949958 [PubMed]

Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in Europe.
Eur J Cancer
Kroese TE, van Laarhoven HWM, Schoppman SF, Deseyne PRAJ, van Cutsem E, Haustermans K, Nafteux P, Thomas M, Obermannova R, Mortensen HR, Nordsmark M, Pfeiffer P, Elme A, Adenis A, Piessen G, Bruns CJ, Lordick F, Gockel I, Moehler M, Gani C, Liakakos T, Reynolds J, Morganti AG, Rosati R, Castoro C, Cellini F, D'Ugo D, Roviello F, Bencivenga M, de Manzoni G, van Berge Henegouwen MI, Hulshof MCCM, van Dieren J, Vollebergh M, van Sandick JW, Jeene P, Muijs CT, Slingerland M, Voncken FEM, Hartgrink H, Creemers GJ, van der Sangen MJC, Nieuwenhuijzen G, Berbee M, Verheij M, Wijnhoven B, Beerepoot LV, Mohammad NH, Mook S, Ruurda JP, Kolodziejczyk P, Polkowski WP, Wyrwicz L, Alsina M, Pera M, Kanonnikoff TF, Cervantes A, Nilsson M, Monig S, Wagner AD, Guckenberger M, Griffiths EA, Smyth E, Hanna GB, Markar S, Chaudry MA, Hawkins MA, Cheong E, van Hillegersberg R, van Rossum PSN, OMEC collaborators.
PMID: 36947929 [PubMed - as supplied by publisher]

The ceramide synthase (CERS/LASS) family: Functions involved in cancer progression.
Cell Oncol (Dordr)
Zhang M, Li Z, Liu Y, Ding X, Wang Y, Fan S.
PMID: 36947340 [PubMed - as supplied by publisher]

Minimally invasive versus open esophagectomy after neoadjuvant therapy for esophageal cancer: a meta-analysis.
J Cardiothorac Surg
Jin Z, Zhu K, Sun J, Zhang J, Zhang B.
PMID: 36945008 [PubMed - indexed for MEDLINE]

Quality-adjusted time without symptoms or toxicity analysis of nivolumab plus chemotherapy versus chemotherapy alone for the management of previously untreated patients with advanced gastric cancer, gastroesophageal junction cancer, or esophageal adenocarcinoma.
Gastric Cancer
Lin D, Nguyen H, Shah R, Qiao Y, Hartman J, Sugarman R.
PMID: 36943511 [PubMed - as supplied by publisher]

Extension of lymph node dissection in the surgical treatment of esophageal and gastroesophageal junction cancer: seven questions and answers.
Future Oncol
Vagliasindi A, Franco FD, Degiuli M, Papis D, Migliore M.
PMID: 36942741 [PubMed - as supplied by publisher]

Intensive Systematic "Train-the-Trainer" Course as an Effective Strategy to Improve Detection of Early Gastric Cancer: A Multicenter Retrospective Study.
J Gastrointest Surg
Luo X, Yao K, Lin X, Lin B, Zhu C, Huang S, Chen Z, Li A, Wang J, Huang Y, Li Z, Liu S, Han Z.
PMID: 36941524 [PubMed - as supplied by publisher]

Cost-effectiveness analysis of PD-1 inhibitors combined with chemotherapy as first-line therapy for advanced esophageal squamous-cell carcinoma in China.
Front Pharmacol
Liu S, Dou L, Li S.
PMID: 36937861 [PubMed]

Postoperative complications after esophagectomy for cancer, neoadjuvant chemoradiotherapy compared to neoadjuvant chemotherapy: A single institutional cohort study.
Clin Transl Radiat Oncol
Ólafsdóttir HS, Dalqvist E, Onjukka E, Klevebro F, Nilsson M, Gagliardi G, Alexandersson von Döbeln G.
PMID: 36936472 [PubMed]

Clinical Outcomes of Radiofrequency Ablation Combined with Transarterial Chemoembolization Using Degradable Starch Microsphere Mixed with Mitomycin C for the Treatment of Non-hepatocellular Carcinoma Malignant Liver Tumors.
Interv Radiol (Higashimatsuyama)
Yoshihara T, Hasegawa T, Sato Y, Yamaura H, Murata S, Chatani S, Tsukii R, Nagasawa K, Tsushima Y, Inaba Y.
PMID: 36936255 [PubMed]

Multi-omics to predict acute radiation esophagitis in patients with lung cancer treated with intensity-modulated radiation therapy.
Eur J Med Res
Zheng X, Guo W, Wang Y, Zhang J, Zhang Y, Cheng C, Teng X, Lam S, Zhou T, Ma Z, Liu R, Wu H, Ge H, Cai J, Li B.
PMID: 36935504 [PubMed - indexed for MEDLINE]

   Artikel 1 - 20 / 32019    Seite 1 von 1601  vorhergehende Seite nächste Seite

Rect Bottom
Adserver Footer





Haben Sie Ihr Passwort vergessen?


Neu bei My Medline?

Melden Sie sich bei My Medline an!


Mehr über My Medline erfahren

mehr >>


Benutzen Sie englische Suchbegriffe für Ihre Suche in



mehr >>


Sky right 1